{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T18:08:09Z","timestamp":1791223689649,"version":"4.1.0"},"reference-count":106,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2021,10,22]],"date-time":"2021-10-22T00:00:00Z","timestamp":1634860800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,10,22]],"date-time":"2021-10-22T00:00:00Z","timestamp":1634860800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Cardiol"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1038\/s41569-021-00631-3","type":"journal-article","created":{"date-parts":[[2021,10,22]],"date-time":"2021-10-22T14:12:56Z","timestamp":1634911976000},"page":"332-341","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":113,"title":["Cardiac involvement in the long-term implications of COVID-19"],"prefix":"10.1038","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7798-0938","authenticated-orcid":false,"given":"Benjamin A.","family":"Satterfield","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1278-6245","authenticated-orcid":false,"given":"Deepak L.","family":"Bhatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5605-900X","authenticated-orcid":false,"given":"Bernard J.","family":"Gersh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,22]]},"reference":[{"key":"631_CR1","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1016\/S2214-109X(20)30464-2","volume":"9","author":"N Dehingia","year":"2021","unstructured":"Dehingia, N. & Raj, A. Sex differences in COVID-19 case fatality: do we know enough? Lancet Glob. Health 9, e14\u2013e15 (2021).","journal-title":"Lancet Glob. Health"},{"key":"631_CR2","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.pcad.2020.05.013","volume":"63","author":"C Bavishi","year":"2020","unstructured":"Bavishi, C. et al. Acute myocardial injury in patients hospitalized with COVID-19 infection: a review. Prog. Cardiovasc. Dis. 63, 682\u2013689 (2020).","journal-title":"Prog. Cardiovasc. Dis."},{"key":"631_CR3","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1001\/jamacardio.2020.1017","volume":"5","author":"T Guo","year":"2020","unstructured":"Guo, T. et al. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiol. 5, 811\u2013818 (2020).","journal-title":"JAMA Cardiol."},{"key":"631_CR4","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1016\/j.ajem.2020.04.048","volume":"38","author":"B Long","year":"2020","unstructured":"Long, B., Brady, W. J., Koyfman, A. & Gottlieb, M. Cardiovascular complications in COVID-19. Am. J. Emerg. Med. 38, 1504\u20131507 (2020).","journal-title":"Am. J. Emerg. Med."},{"key":"631_CR5","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1177\/10742484211011026","volume":"26","author":"AS Manolis","year":"2021","unstructured":"Manolis, A. S., Manolis, A. A., Manolis, T. A. & Melita, H. COVID-19 and acute myocardial injury and infarction: related mechanisms and emerging challenges. J. Cardiovasc. Pharmacol. Ther. 26, 399\u2013414 (2021).","journal-title":"J. Cardiovasc. Pharmacol. Ther."},{"key":"631_CR6","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1093\/eurheartj\/ehab145","volume":"42","author":"MG Friedrich","year":"2021","unstructured":"Friedrich, M. G. & Cooper, L. T. Jr What we (don\u2019t) know about myocardial injury after COVID-19. Eur. Heart J. 42, 1879\u20131882 (2021).","journal-title":"Eur. Heart J."},{"key":"631_CR7","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1093\/clinchem\/hvab111","volume":"67","author":"A Bularga","year":"2021","unstructured":"Bularga, A., Chapman, A. R. & Mills, N. L. Mechanisms of myocardial injury in COVID-19. Clin. Chem. 67, 1044\u20131046 (2021).","journal-title":"Clin. Chem."},{"key":"631_CR8","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1093\/eurheartj\/ehaa408","volume":"41","author":"S Shi","year":"2020","unstructured":"Shi, S. et al. Characteristics and clinical significance of myocardial injury in patients with severe coronavirus disease 2019. Eur. Heart J. 41, 2070\u20132079 (2020).","journal-title":"Eur. Heart J."},{"key":"631_CR9","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1136\/heartjnl-2020-317007","volume":"106","author":"J-F Wei","year":"2020","unstructured":"Wei, J.-F. et al. Acute myocardial injury is common in patients with COVID-19 and impairs their prognosis. Heart 106, 1154\u20131159 (2020).","journal-title":"Heart"},{"key":"631_CR10","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.amjmed.2020.09.046","volume":"134","author":"HK Siddiqi","year":"2021","unstructured":"Siddiqi, H. K. et al. Increased prevalence of myocardial injury in patients with SARS-CoV-2 viremia. Am. J. Med. 134, 542\u2013546 (2021).","journal-title":"Am. J. Med."},{"key":"631_CR11","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/s41591-021-01283-z","volume":"27","author":"A Nalbandian","year":"2021","unstructured":"Nalbandian, A. et al. Post-acute COVID-19 syndrome. Nat. Med. 27, 601\u2013615 (2021).","journal-title":"Nat. Med."},{"key":"631_CR12","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1016\/j.mayocp.2021.04.008","volume":"96","author":"BA Satterfield","year":"2021","unstructured":"Satterfield, B. A., Dikilitas, O. & Kullo, I. J. Leveraging the electronic health record to address the COVID-19 pandemic. Mayo Clin. Proc. 96, 1592\u20131608 (2021).","journal-title":"Mayo Clin. Proc."},{"key":"631_CR13","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1016\/j.jacc.2020.09.594","volume":"76","author":"M Vaduganathan","year":"2020","unstructured":"Vaduganathan, M. et al. Regulation of cardiovascular therapies during the COVID-19 public health emergency. J. Am. Coll. Cardiol. 76, 2517\u20132521 (2020).","journal-title":"J. Am. Coll. Cardiol."},{"key":"631_CR14","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/s41569-020-00439-7","volume":"17","author":"P Gaba","year":"2020","unstructured":"Gaba, P. & Bhatt, D. L. The COVID-19 pandemic: a catalyst to improve clinical trials. Nat. Rev. Cardiol. 17, 673\u2013675 (2020).","journal-title":"Nat. Rev. Cardiol."},{"key":"631_CR15","first-page":"E81","volume":"32","author":"X Wang","year":"2020","unstructured":"Wang, X. & Bhatt, D. L. COVID-19: an unintended force for medical revolution. J. Invasive Cardiol. 32, E81\u2013E82 (2020).","journal-title":"J. Invasive Cardiol."},{"key":"631_CR16","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.018274","volume":"9","author":"S Selvaraj","year":"2020","unstructured":"Selvaraj, S. et al. The landscape of cardiovascular clinical trials in the United States initiated before and during COVID-19. J. Am. Heart Assoc. 9, e018274 (2020).","journal-title":"J. Am. Heart Assoc."},{"key":"631_CR17","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1001\/jama.2021.3071","volume":"325","author":"E L\u00f3pez-Medina","year":"2021","unstructured":"L\u00f3pez-Medina, E. et al. Effect of ivermectin on time to resolution of symptoms among adults with mild COVID-19: a randomized clinical trial. JAMA 325, 1426\u20131435 (2021).","journal-title":"JAMA"},{"key":"631_CR18","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1001\/jama.2021.4152","volume":"325","author":"P Sadeghipour","year":"2021","unstructured":"Sadeghipour, P. et al. Effect of intermediate-dose vs standard-dose prophylactic anticoagulation on thrombotic events, extracorporeal membrane oxygenation treatment, or mortality among patients with COVID-19 admitted to the intensive care unit: the INSPIRATION randomized clinical trial. JAMA 325, 1620\u20131630 (2021).","journal-title":"JAMA"},{"key":"631_CR19","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1002\/jmv.26695","volume":"93","author":"G Zhang","year":"2021","unstructured":"Zhang, G., Wu, Y., Xu, R. & Du, X. Effects of renin-angiotensin-aldosterone system inhibitors on disease severity and mortality in patients with COVID-19: a meta-analysis. J. Med. Virol. 93, 2287\u20132300 (2021).","journal-title":"J. Med. Virol."},{"key":"631_CR20","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.jacc.2020.05.041","volume":"76","author":"E Bagiella","year":"2020","unstructured":"Bagiella, E., Bhatt, D. L. & Gaudino, M. The consequences of the COVID-19 pandemic on non-COVID-19 clinical trials. J. Am. Coll. Cardiol. 76, 342\u2013345 (2020).","journal-title":"J. Am. Coll. Cardiol."},{"key":"631_CR21","first-page":"jrm00063","volume":"52","author":"H Ahmed","year":"2020","unstructured":"Ahmed, H. et al. Long-term clinical outcomes in survivors of severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS) coronavirus outbreaks after hospitalisation or ICU admission: a systematic review and meta-analysis. J. Rehabil. Med. 52, jrm00063 (2020).","journal-title":"J. Rehabil. Med."},{"key":"631_CR22","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1136\/thx.2004.030205","volume":"60","author":"D Hui","year":"2005","unstructured":"Hui, D. et al. Impact of severe acute respiratory syndrome (SARS) on pulmonary function, functional capacity and quality of life in a cohort of survivors. Thorax 60, 401\u2013409 (2005).","journal-title":"Thorax"},{"key":"631_CR23","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1001\/archinternmed.2009.384","volume":"169","author":"MH-B Lam","year":"2009","unstructured":"Lam, M. H.-B. et al. Mental morbidities and chronic fatigue in severe acute respiratory syndrome survivors: long-term follow-up. Arch. Intern. Med. 169, 2142\u20132147 (2009).","journal-title":"Arch. Intern. Med."},{"key":"631_CR24","doi-asserted-by":"crossref","first-page":"59","DOI":"10.30773\/pi.2018.10.22.3","volume":"16","author":"SH Lee","year":"2019","unstructured":"Lee, S. H. et al. Depression as a mediator of chronic fatigue and post-traumatic stress symptoms in middle east respiratory syndrome survivors. Psychiatry Investig. 16, 59\u201364 (2019).","journal-title":"Psychiatry Investig."},{"key":"631_CR25","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2377-11-37","volume":"11","author":"H Moldofsky","year":"2011","unstructured":"Moldofsky, H. & Patcai, J. Chronic widespread musculoskeletal pain, fatigue, depression and disordered sleep in chronic post-SARS syndrome; a case-controlled study. BMC Neurol. 11, 37 (2011).","journal-title":"BMC Neurol."},{"key":"631_CR26","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1183\/09031936.04.00007104","volume":"24","author":"KC Ong","year":"2004","unstructured":"Ong, K. C. et al. Pulmonary function and exercise capacity in survivors of severe acute respiratory syndrome. Eur. Respir. J. 24, 436\u2013442 (2004).","journal-title":"Eur. Respir. J."},{"key":"631_CR27","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1177\/070674370705200405","volume":"52","author":"AM Lee","year":"2007","unstructured":"Lee, A. M. et al. Stress and psychological distress among SARS survivors 1 year after the outbreak. Can. J. Psychiatry 52, 233\u2013240 (2007).","journal-title":"Can. J. Psychiatry"},{"key":"631_CR28","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1001\/jama.2020.22717","volume":"324","author":"SD Datta","year":"2020","unstructured":"Datta, S. D., Talwar, A. & Lee, J. T. A proposed framework and timeline of the spectrum of disease due to SARS-CoV-2 infection: Illness beyond acute infection and public health implications. JAMA 324, 2251\u20132252 (2020).","journal-title":"JAMA"},{"key":"631_CR29","doi-asserted-by":"crossref","first-page":"m3026","DOI":"10.1136\/bmj.m3026","volume":"370","author":"T Greenhalgh","year":"2020","unstructured":"Greenhalgh, T., Knight, M., Buxton, M. & Husain, L. Management of post-acute Covid-19 in primary care. BMJ 370, m3026 (2020).","journal-title":"BMJ"},{"key":"631_CR30","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1016\/j.jcmg.2020.05.004","volume":"13","author":"L Huang","year":"2020","unstructured":"Huang, L. et al. Cardiac involvement in patients recovered from COVID-2019 identified using magnetic resonance imaging. JACC Cardiovasc. Imaging 13, 2330\u20132339 (2020).","journal-title":"JACC Cardiovasc. Imaging"},{"key":"631_CR31","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0140-6736(20)32705-7","volume":"397","author":"R Gorna","year":"2021","unstructured":"Gorna, R. et al. Long COVID guidelines need to reflect lived experience. Lancet 397, 455\u2013457 (2021).","journal-title":"Lancet"},{"key":"631_CR32","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.0830","volume":"4","author":"JK Logue","year":"2021","unstructured":"Logue, J. K. et al. Sequelae in adults at 6 months after COVID-19 infection. JAMA Netw. Open. 4, e210830 (2021).","journal-title":"JAMA Netw. Open."},{"key":"631_CR33","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1001\/jama.2020.12603","volume":"324","author":"A Carf\u00ec","year":"2020","unstructured":"Carf\u00ec, A., Bernabei, R. & Landi, F. Persistent symptoms in patients after acute COVID-19. JAMA 324, 603\u2013605 (2020).","journal-title":"JAMA"},{"key":"631_CR34","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.cmi.2020.09.052","volume":"27","author":"C Carvalho-Schneider","year":"2021","unstructured":"Carvalho-Schneider, C. et al. Follow-up of adults with noncritical COVID-19 two months after symptom onset. Clin. Microbiol. Infect. 27, 258\u2013263 (2021).","journal-title":"Clin. Microbiol. Infect."},{"key":"631_CR35","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S0140-6736(20)32656-8","volume":"397","author":"C Huang","year":"2021","unstructured":"Huang, C. et al. 6-Month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet 397, 220\u2013232 (2021).","journal-title":"Lancet"},{"key":"631_CR36","doi-asserted-by":"crossref","DOI":"10.1186\/s12916-021-02003-7","volume":"19","author":"\u00c1 Romero-Duarte","year":"2021","unstructured":"Romero-Duarte, \u00c1. et al. Sequelae, persistent symptomatology and outcomes after COVID-19 hospitalization: the ANCOHVID multicentre 6-month follow-up study. BMC Med. 19, 129 (2021).","journal-title":"BMC Med."},{"key":"631_CR37","doi-asserted-by":"crossref","first-page":"497","DOI":"10.3390\/vaccines9050497","volume":"9","author":"HC Maltezou","year":"2021","unstructured":"Maltezou, H. C., Pavli, A. & Tsakris, A. Post-COVID syndrome: an insight on its pathogenesis. Vaccines 9, 497 (2021).","journal-title":"Vaccines"},{"key":"631_CR38","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1007\/s42399-020-00454-2","volume":"2","author":"S Babapoor-Farrokhran","year":"2020","unstructured":"Babapoor-Farrokhran, S., Rasekhi, R. T., Gill, D., Babapoor, S. & Amanullah, A. Arrhythmia in COVID-19. SN Compr. Clin. Med. 2, 1430\u20131435 (2020).","journal-title":"SN Compr. Clin. Med."},{"key":"631_CR39","volume":"13","author":"SM Kochav","year":"2020","unstructured":"Kochav, S. M. et al. Cardiac arrhythmias in COVID-19. Infect. Circ. Arrhythm. Electrophysiol. 13, e008719 (2020).","journal-title":"Infect. Circ. Arrhythm. Electrophysiol."},{"key":"631_CR40","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/jama.2020.1585","volume":"323","author":"D Wang","year":"2020","unstructured":"Wang, D. et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 323, 1061\u20131069 (2020).","journal-title":"JAMA"},{"key":"631_CR41","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1056\/NEJMc2010419","volume":"382","author":"P Goyal","year":"2020","unstructured":"Goyal, P. et al. Clinical characteristics of Covid-19 in New York City. N. Engl. J. Med. 382, 2372\u20132374 (2020).","journal-title":"N. Engl. J. Med."},{"key":"631_CR42","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.jacep.2020.05.015","volume":"6","author":"CM Colon","year":"2020","unstructured":"Colon, C. M. et al. Atrial arrhythmias in COVID-19 patients. Clin. Electrophysiol. 6, 1189\u20131190 (2020).","journal-title":"Clin. Electrophysiol."},{"key":"631_CR43","volume":"16","author":"M Zhou","year":"2021","unstructured":"Zhou, M. et al. Cardiovascular sequalae in uncomplicated COVID-19 survivors. PLoS One 16, e0246732 (2021).","journal-title":"PLoS One"},{"key":"631_CR44","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.120.009458","volume":"14","author":"EJ Coromilas","year":"2021","unstructured":"Coromilas, E. J. et al. Worldwide survey of COVID-19-associated arrhythmias. Circ. Arrhythm. Electrophysiol. 14, e009458 (2021).","journal-title":"Circ. Arrhythm. Electrophysiol."},{"key":"631_CR45","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s10840-020-00789-9","volume":"59","author":"R Gopinathannair","year":"2020","unstructured":"Gopinathannair, R. et al. COVID-19 and cardiac arrhythmias: a global perspective on arrhythmia characteristics and management strategies. J. Interv. Card. Electrophysiol. 59, 329\u2013336 (2020).","journal-title":"J. Interv. Card. Electrophysiol."},{"key":"631_CR46","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.120.009375","volume":"14","author":"EG Spinoni","year":"2021","unstructured":"Spinoni, E. G. et al. Contribution of atrial fibrillation to in-hospital mortality in patients with COVID-19. Circ. Arrhythm. Electrophysiol. 14, e009375 (2021).","journal-title":"Circ. Arrhythm. Electrophysiol."},{"key":"631_CR47","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/j.jacep.2021.02.009","volume":"7","author":"DR Musikantow","year":"2021","unstructured":"Musikantow, D. R. et al. Atrial fibrillation in patients hospitalized with COVID-19: incidence, predictors, outcomes and comparison to influenza. JACC Clin. Electrophysiol. 7, 1120\u20131130 (2021).","journal-title":"JACC Clin. Electrophysiol."},{"key":"631_CR48","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s12026-021-09185-5","volume":"69","author":"S Blitshteyn","year":"2021","unstructured":"Blitshteyn, S. & Whitelaw, S. Postural orthostatic tachycardia syndrome (POTS) and other autonomic disorders after COVID-19 infection: a case series of 20 patients. Immunol. Res. 69, 205\u2013211 (2021).","journal-title":"Immunol. Res."},{"key":"631_CR49","volume":"4","author":"GA Rubin","year":"2021","unstructured":"Rubin, G. A. et al. Cardiac corrected QT interval changes among patients treated for COVID-19 infection during the early phase of the pandemic. JAMA Netw. Open 4, e216842 (2021).","journal-title":"JAMA Netw. Open"},{"key":"631_CR50","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jacep.2020.07.016","volume":"7","author":"TF O\u2019Connell","year":"2021","unstructured":"O\u2019Connell, T. F. et al. Hydroxychloroquine\/azithromycin therapy and QT prolongation in hospitalized patients with COVID-19. Clin. Electrophysiol. 7, 16\u201325 (2021).","journal-title":"Clin. Electrophysiol."},{"key":"631_CR51","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.120.008688","volume":"13","author":"O Oren","year":"2020","unstructured":"Oren, O. et al. Use of chloroquine and hydroxychloroquine in COVID-19 and cardiovascular implications: understanding safety discrepancies to improve interpretation and design of clinical trials. Circ. Arrhythm. Electrophysiol. 13, e008688 (2020).","journal-title":"Circ. Arrhythm. Electrophysiol."},{"key":"631_CR52","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1161\/CIRCULATIONAHA.120.049252","volume":"142","author":"DS Knight","year":"2020","unstructured":"Knight, D. S. et al. COVID-19: myocardial injury in survivors. Circulation 142, 1120\u20131122 (2020).","journal-title":"Circulation"},{"key":"631_CR53","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1001\/jamacardio.2020.3557","volume":"5","author":"VO Puntmann","year":"2020","unstructured":"Puntmann, V. O. et al. Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19). JAMA Cardiol. 5, 1265\u20131273 (2020).","journal-title":"JAMA Cardiol."},{"key":"631_CR54","first-page":"116","volume":"6","author":"S Rajpal","year":"2021","unstructured":"Rajpal, S. et al. Cardiovascular magnetic resonance findings in competitive athletes recovering from COVID-19 infection. JAMA Cardiol. 6, 116\u2013118 (2021).","journal-title":"JAMA Cardiol."},{"key":"631_CR55","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/j.jcmg.2020.11.014","volume":"14","author":"H Vago","year":"2020","unstructured":"Vago, H., Szabo, L., Dohy, Z. & Merkely, B. Cardiac magnetic resonance findings in patients recovered from COVID-19: initial experiences in elite athletes. IJACC Cardiovasc. Imaging 14, 1279\u20131281 (2020).","journal-title":"IJACC Cardiovasc. Imaging"},{"key":"631_CR56","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1093\/eurheartj\/ehab075","volume":"42","author":"T Kotecha","year":"2021","unstructured":"Kotecha, T. et al. Patterns of myocardial injury in recovered troponin-positive COVID-19 patients assessed by cardiovascular magnetic resonance. Eur. Heart J. 42, 1866\u20131878 (2021).","journal-title":"Eur. Heart J."},{"key":"631_CR57","doi-asserted-by":"crossref","first-page":"100683","DOI":"10.1016\/j.eclinm.2020.100683","volume":"31","author":"B Raman","year":"2021","unstructured":"Raman, B. et al. Medium-term effects of SARS-CoV-2 infection on multiple vital organs, exercise capacity, cognition, quality of life and mental health, post-hospital discharge. EClinicalMedicine 31, 100683 (2021).","journal-title":"EClinicalMedicine"},{"key":"631_CR58","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1002\/jmri.27513","volume":"53","author":"A Ma\u0142ek","year":"2021","unstructured":"Ma\u0142ek, A. et al. Cardiac involvement in consecutive elite athletes recovered from Covid-19: a magnetic resonance study. J. Magn. Reson. Imaging 53, 1723\u20131729 (2021).","journal-title":"J. Magn. Reson. Imaging"},{"key":"631_CR59","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1001\/jamacardio.2020.7444","volume":"6","author":"J Starekova","year":"2021","unstructured":"Starekova, J. et al. Evaluation for myocarditis in competitive student athletes recovering from coronavirus disease 2019 with cardiac magnetic resonance imaging. JAMA Cardiol. 6, 945\u2013950 (2021).","journal-title":"JAMA Cardiol."},{"key":"631_CR60","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1161\/CIRCULATIONAHA.120.052573","volume":"143","author":"DE Clark","year":"2021","unstructured":"Clark, D. E. et al. COVID-19 myocardial pathology evaluation in AthleTEs with cardiac magnetic resonance (COMPETE CMR). Circulation 143, 609\u2013612 (2021).","journal-title":"Circulation"},{"key":"631_CR61","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1001\/jamacardio.2021.0565","volume":"6","author":"MW Martinez","year":"2021","unstructured":"Martinez, M. W. et al. Prevalence of inflammatory heart disease among professional athletes with prior COVID-19 infection who received systematic return-to-play cardiac screening. JAMA Cardiol. 6, 745\u2013752 (2021).","journal-title":"JAMA Cardiol."},{"key":"631_CR62","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1161\/CIRCULATIONAHA.121.054824","volume":"144","author":"N Moulson","year":"2021","unstructured":"Moulson, N. et al. SARS-CoV-2 cardiac involvement in young competitive athletes. Circulation 144, 256\u2013266 (2021).","journal-title":"Circulation"},{"key":"631_CR63","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/jmri.27534","volume":"54","author":"C Pan","year":"2021","unstructured":"Pan, C. et al. Cardiac T1 and T2 mapping showed myocardial involvement in recovered COVID-19 patients initially considered devoid of cardiac damage. J. Magn. Reson. Imaging 54, 421\u2013428 (2021).","journal-title":"J. Magn. Reson. Imaging"},{"key":"631_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmg.2021.04.011","author":"G Joy","year":"2021","unstructured":"Joy, G. et al. Prospective case-control study of cardiovascular abnormalities 6 months following mild COVID-19 in healthcare workers. IJACC Cardiovasc. Imaging https:\/\/doi.org\/10.1016\/j.jcmg.2021.04.011 (2021).","journal-title":"IJACC Cardiovasc. Imaging"},{"key":"631_CR65","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1161\/CIRCULATIONAHA.121.053982","volume":"143","author":"BS Hendrickson","year":"2021","unstructured":"Hendrickson, B. S. et al. Cardiovascular evaluation after COVID-19 in 137 collegiate athletes: results of an algorithm-guided screening. Circulation 143, 1926\u20131928 (2021).","journal-title":"Circulation"},{"key":"631_CR66","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1001\/jamacardio.2021.2065","volume":"6","author":"CJ Daniels","year":"2021","unstructured":"Daniels, C. J. et al. Prevalence of clinical and subclinical myocarditis in competitive athletes with recent SARS-CoV-2 infection: results from the Big Ten COVID-19 Cardiac Registry. JAMA Cardiol. 6, 1078\u20131087 (2021).","journal-title":"JAMA Cardiol."},{"key":"631_CR67","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1001\/jamacardio.2021.2079","volume":"6","author":"JE Udelson","year":"2021","unstructured":"Udelson, J. E., Rowin, E. J. & Maron, B. J. Return to play for athletes after COVID-19 infection: the fog begins to clear. JAMA Cardiol. 6, 997\u2013999 (2021).","journal-title":"JAMA Cardiol."},{"key":"631_CR68","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1161\/HYPERTENSIONAHA.121.17099","volume":"77","author":"H Gu","year":"2021","unstructured":"Gu, H. et al. First-phase ejection fraction, a measure of preclinical heart failure, is strongly associated with increased mortality in patients with COVID-19. Hypertension 77, 2014\u20132022 (2021).","journal-title":"Hypertension"},{"key":"631_CR69","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.018477","volume":"10","author":"KK Manocha","year":"2021","unstructured":"Manocha, K. K. et al. Troponin and other biomarker levels and outcomes among patients hospitalized with COVID-19: derivation and validation of the HA2T2 COVID-19 mortality risk score. J. Am. Heart Assoc. 10, e018477 (2021).","journal-title":"J. Am. Heart Assoc."},{"key":"631_CR70","doi-asserted-by":"crossref","first-page":"107300","DOI":"10.1016\/j.carpath.2020.107300","volume":"50","author":"MK Halushka","year":"2021","unstructured":"Halushka, M. K. & Vander Heide, R. S. Myocarditis is rare in COVID-19 autopsies: cardiovascular findings across 277 post-mortem examinations. Cardiovasc. Pathol. 50, 107300 (2021).","journal-title":"Cardiovasc. Pathol."},{"key":"631_CR71","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/rmv.2146","volume":"31","author":"B Gallo Marin","year":"2021","unstructured":"Gallo Marin, B. et al. Predictors of COVID-19 severity: a literature review. Rev. Med. Virol. 31, 1\u201310 (2021).","journal-title":"Rev. Med. Virol."},{"key":"631_CR72","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1001\/jamainternmed.2020.5313","volume":"181","author":"JW Cunningham","year":"2021","unstructured":"Cunningham, J. W. et al. Clinical outcomes in young US adults hospitalized with COVID-19. JAMA Intern. Med. 181, 379\u2013381 (2021).","journal-title":"JAMA Intern. Med."},{"key":"631_CR73","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.accpm.2020.05.015","volume":"39","author":"M Jacquet-Lagr\u00e8ze","year":"2020","unstructured":"Jacquet-Lagr\u00e8ze, M., Riad, Z., Hugon-Vallet, E., Ferraris, A. & Fellahi, J.-L. Left ventricular dysfunction in COVID-19: a diagnostic issue. Anaesth. Crit. Care Pain. Med. 39, 393 (2020).","journal-title":"Anaesth. Crit. Care Pain. Med."},{"key":"631_CR74","volume":"13","author":"CW Tsao","year":"2020","unstructured":"Tsao, C. W., Strom, J. B., Chang, J. D. & Manning, W. J. COVID-19-associated stress (Takotsubo) cardiomyopathy. Circ. Cardiovasc. Imaging 13, e011222 (2020).","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"631_CR75","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1111\/jocs.15251","volume":"36","author":"D Kir","year":"2021","unstructured":"Kir, D., Beer, N. & De Marchena, E. J. Takotsubo cardiomyopathy caused by emotional stressors in the coronavirus disease 2019 (COVID-19) pandemic era. J. Card. Surg. 36, 764\u2013769 (2021).","journal-title":"J. Card. Surg."},{"key":"631_CR76","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1002\/jmv.26581","volume":"93","author":"J Finsterer","year":"2021","unstructured":"Finsterer, J. & St\u00f6llberger, C. SARS-CoV-2 triggered Takotsubo in 38 patients. J. Med. Virol. 93, 1236\u20131238 (2021).","journal-title":"J. Med. Virol."},{"key":"631_CR77","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.amjcard.2020.06.010","volume":"130","author":"F Annie","year":"2020","unstructured":"Annie, F., Bates, M. C., Nanjundappa, A., Bhatt, D. L. & Alkhouli, M. Prevalence and outcomes of acute ischemic stroke among patients \u226450 years of age with laboratory confirmed COVID-19 infection. Am. J. Cardiol. 130, 169\u2013170 (2020).","journal-title":"Am. J. Cardiol."},{"key":"631_CR78","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1055\/a-1366-9656","volume":"121","author":"SL Cohen","year":"2021","unstructured":"Cohen, S. L. et al. Prevalence and predictors of venous thromboembolism or mortality in hospitalized COVID-19 patients. Thromb. Haemost. 121, 1043\u20131053 (2021).","journal-title":"Thromb. Haemost."},{"key":"631_CR79","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1093\/eurheartj\/ehaa893","volume":"42","author":"CJ O\u2019Shea","year":"2021","unstructured":"O\u2019Shea, C. J. et al. Ventricular arrhythmia burden during the coronavirus disease 2019 (COVID-19) pandemic. Eur. Heart J. 42, 520\u2013528 (2021).","journal-title":"Eur. Heart J."},{"key":"631_CR80","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.thromres.2020.11.017","volume":"198","author":"F Scudiero","year":"2021","unstructured":"Scudiero, F. et al. Pulmonary embolism in COVID-19 patients: prevalence, predictors and clinical outcome. Thromb. Res. 198, 34\u201339 (2021).","journal-title":"Thromb. Res."},{"key":"631_CR81","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1007\/s11239-020-02370-7","volume":"51","author":"M Vlachou","year":"2021","unstructured":"Vlachou, M. et al. Pulmonary thrombosis in Covid-19: before, during and after hospital admission. J. Thromb. Thrombolysis 51, 978\u2013984 (2021).","journal-title":"J. Thromb. Thrombolysis"},{"key":"631_CR82","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s10286-021-00798-2","volume":"31","author":"SR Raj","year":"2021","unstructured":"Raj, S. R. et al. Long-COVID postural tachycardia syndrome: an American Autonomic Society statement. Clin. Auton. Res. 31, 365\u2013368 (2021).","journal-title":"Clin. Auton. Res."},{"key":"631_CR83","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jacc.2020.05.038","volume":"76","author":"AS Bhatt","year":"2020","unstructured":"Bhatt, A. S. et al. Fewer hospitalizations for acute cardiovascular conditions during the COVID-19 pandemic. J. Am. Coll. Cardiol. 76, 280\u2013288 (2020).","journal-title":"J. Am. Coll. Cardiol."},{"key":"631_CR84","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1093\/ehjqcco\/qcaa038","volume":"6","author":"L Toner","year":"2020","unstructured":"Toner, L. et al. Acute coronary syndromes undergoing percutaneous coronary intervention in the COVID-19 era: comparable case volumes but delayed symptom onset to hospital presentation. Eur. Heart J. Qual. Care Clin. Outcomes 6, 225\u2013226 (2020).","journal-title":"Eur. Heart J. Qual. Care Clin. Outcomes"},{"key":"631_CR85","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1093\/eurheartj\/ehaa567","volume":"41","author":"M Nicholls","year":"2020","unstructured":"Nicholls, M. COVID-19 and cardiovascular disease. Eur. Heart J. 41, 2727\u20132729 (2020).","journal-title":"Eur. Heart J."},{"key":"631_CR86","doi-asserted-by":"crossref","first-page":"B91","DOI":"10.1016\/j.jacc.2020.09.230","volume":"76","author":"T Kite","year":"2020","unstructured":"Kite, T. et al. TCT CONNECT-215 demographics and in-hospital outcomes of COVID-19 patients undergoing an invasive strategy for acute coronary syndrome: the global multi-centre prospective COVID-ACS registry [abstract]. J. Am. Coll. Cardiol. 76, B91 (2020).","journal-title":"J. Am. Coll. Cardiol."},{"key":"631_CR87","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1016\/j.jacc.2021.02.055","volume":"77","author":"S Garcia","year":"2021","unstructured":"Garcia, S. et al. Initial findings from the North American COVID-19 myocardial infarction registry. J. Am. Coll. Cardiol. 77, 1994\u20132003 (2021).","journal-title":"J. Am. Coll. Cardiol."},{"key":"631_CR88","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1253\/circj.CJ-20-0800","volume":"85","author":"NW Chew","year":"2021","unstructured":"Chew, N. W. et al. Impact of the COVID-19 Pandemic on door-to-balloon time for primary percutaneous coronary intervention \u2014 results from the Singapore Western STEMI network. Circ. J. 85, 139\u2013149 (2021).","journal-title":"Circ. J."},{"key":"631_CR89","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.3390\/jcm9072183","volume":"9","author":"SJ Reinstadler","year":"2020","unstructured":"Reinstadler, S. J. et al. Effect of the COVID-19 pandemic on treatment delays in patients with ST-segment elevation myocardial infarction. J. Clin. Med. 9, 2183 (2020).","journal-title":"J. Clin. Med."},{"key":"631_CR90","doi-asserted-by":"crossref","DOI":"10.1001\/jamahealthforum.2020.1463","volume":"1","author":"MG Findling","year":"2020","unstructured":"Findling, M. G., Blendon, R. J. & Benson, J. M. Delayed care with harmful health consequences \u2014 reported experiences from national surveys during coronavirus disease 2019. JAMA Health Forum 1, e201463 (2020).","journal-title":"JAMA Health Forum"},{"key":"631_CR91","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1001\/jama.2020.26443","volume":"325","author":"L Lopez","year":"2021","unstructured":"Lopez, L., Hart, L. H. & Katz, M. H. Racial and ethnic health disparities related to COVID-19. JAMA 325, 719\u2013720 (2021).","journal-title":"JAMA"},{"key":"631_CR92","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/HCO.0000000000000847","volume":"36","author":"YK Aleligne","year":"2021","unstructured":"Aleligne, Y. K., Appiah, D. & Ebong, I. A. Racial disparities in coronavirus disease 2019 (COVID-19) outcomes. Curr. Opin. Cardiol. 36, 360\u2013366 (2021).","journal-title":"Curr. Opin. Cardiol."},{"key":"631_CR93","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1093\/cid\/ciaa815","volume":"72","author":"DBG Tai","year":"2021","unstructured":"Tai, D. B. G., Shah, A., Doubeni, C. A., Sia, I. G. & Wieland, M. L. The disproportionate impact of COVID-19 on racial and ethnic minorities in the United States. Clin. Infect. Dis. 72, 703\u2013706 (2021).","journal-title":"Clin. Infect. Dis."},{"key":"631_CR94","doi-asserted-by":"crossref","DOI":"10.2196\/22581","volume":"7","author":"P Phiri","year":"2021","unstructured":"Phiri, P., Delanerolle, G., Al-Sudani, A. & Rathod, S. COVID-19 and black, Asian, and minority ethnic communities: a complex relationship without just cause. JMIR Public Health Surveill. 7, e22581 (2021).","journal-title":"JMIR Public Health Surveill."},{"key":"631_CR95","unstructured":"Fryar, C. D., Carroll, M. D. & Ogden, C. Prevalence of Overweight, Obesity, and Severe Obesity Among Adults Age 20 and Over: United States, 1960-1962 Through 2015-2016 (US National Center for Health Statistics, 2020)."},{"key":"631_CR96","unstructured":"CDC. National Diabetes Statistics Report, 2020. Estimates of diabetes and its burden in the United States. CDC.gov https:\/\/www.cdc.gov\/diabetes\/pdfs\/data\/statistics\/national-diabetes-statistics-report.pdf (2020)."},{"key":"631_CR97","unstructured":"CDC. Chronic Kidney Disease in the United States. CDC.gov https:\/\/www.cdc.gov\/kidneydisease\/pdf\/Chronic-Kidney-Disease-in-the-US-2021-h.pdf (2021)."},{"key":"631_CR98","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1016\/j.vaccine.2018.02.030","volume":"36","author":"J Kuntz","year":"2018","unstructured":"Kuntz, J., Crane, B., Weinmann, S. & Naleway, A. L. Myocarditis and pericarditis are rare following live viral vaccinations in adults. Vaccine 36, 1524\u20131527 (2018).","journal-title":"Vaccine"},{"key":"631_CR99","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1001\/jamacardio.2021.2828","volume":"6","author":"HW Kim","year":"2021","unstructured":"Kim, H. W. et al. Patients with acute myocarditis following mRNA COVID-19 vaccination. JAMA Cardiol. 6, 1196\u20131201 (2021).","journal-title":"JAMA Cardiol."},{"key":"631_CR100","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1001\/jamacardio.2021.2833","volume":"6","author":"J Montgomery","year":"2021","unstructured":"Montgomery, J. et al. Myocarditis following immunization with mRNA COVID-19 vaccines in members of the US military. JAMA Cardiol. 6, 1202\u20131206 (2021).","journal-title":"JAMA Cardiol."},{"key":"631_CR101","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1161\/CIRCULATIONAHA.121.056135","volume":"144","author":"B Bozkurt","year":"2021","unstructured":"Bozkurt, B., Kamat, I. & Hotez, P. J. Myocarditis with COVID-19 mRNA Vaccines. Circulation 144, 471\u2013484 (2021).","journal-title":"Circulation"},{"key":"631_CR102","doi-asserted-by":"publisher","unstructured":"Witberg, G. et al. Myocarditis after Covid-19 vaccination in a large health care organization. N. Engl. J. Med. https:\/\/doi.org\/10.1056\/NEJMoa2110737 (2021).","DOI":"10.1056\/NEJMoa2110737"},{"key":"631_CR103","doi-asserted-by":"publisher","unstructured":"Mevorach, D. et al. Myocarditis after BNT162b2 mRNA vaccine against Covid-19 in Israel. N. Engl. J. Med. https:\/\/doi.org\/10.1056\/NEJMoa2109730 (2021).","DOI":"10.1056\/NEJMoa2109730"},{"key":"631_CR104","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1056\/NEJMc2109975","volume":"385","author":"AK Verma","year":"2021","unstructured":"Verma, A. K., Lavine, K. J. & Lin, C.-Y. Myocarditis after Covid-19 mRNA vaccination. N. Engl. J. Med. 385, 1332\u20131334 (2021).","journal-title":"N. Engl. J. Med."},{"key":"631_CR105","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2021.3471","author":"A Dionne","year":"2021","unstructured":"Dionne, A. et al. Association of myocarditis with BNT162b2 messenger RNA COVID-19 vaccine in a case series of children. JAMA Cardiol. https:\/\/doi.org\/10.1001\/jamacardio.2021.3471 (2021).","journal-title":"JAMA Cardiol."},{"key":"631_CR106","doi-asserted-by":"crossref","first-page":"3483","DOI":"10.1002\/ehf2.13466","volume":"8","author":"D Richter","year":"2021","unstructured":"Richter, D. et al. Late phase of COVID-19 pandemic in general cardiology. A position paper of the ESC Council for Cardiology Practice. ESC Heart Fail. 8, 3483\u20133494 (2021).","journal-title":"ESC Heart Fail."}],"updated-by":[{"DOI":"10.1038\/s41569-021-00641-1","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000}}],"container-title":["Nature Reviews Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41569-021-00631-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41569-021-00631-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41569-021-00631-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,19]],"date-time":"2022-04-19T13:31:49Z","timestamp":1650375109000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41569-021-00631-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,22]]},"references-count":106,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["631"],"URL":"https:\/\/doi.org\/10.1038\/s41569-021-00631-3","relation":{"correction":[{"id-type":"doi","id":"10.1038\/s41569-021-00641-1","asserted-by":"object"}]},"ISSN":["1759-5002","1759-5010"],"issn-type":[{"value":"1759-5002","type":"print"},{"value":"1759-5010","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,22]]},"assertion":[{"value":"27 September 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2021","order":3,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":4,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":5,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41569-021-00641-1","URL":"https:\/\/doi.org\/10.1038\/s41569-021-00641-1","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"D.L.B. declares the following relationships. Advisory Board: Cardax, CellProthera, Cereno Scientific, Elsevier Practice Update Cardiology, Janssen, Level Ex, Medscape Cardiology, MyoKardia, NirvaMed, Novo Nordisk, PhaseBio, PLx Pharma, Regado Biosciences; Board of Directors: Boston VA Research Institute, Society of Cardiovascular Patient Care, TobeSoft; Chair: Inaugural Chair, American Heart Association Quality Oversight Committee; Data Monitoring Committees: Baim Institute for Clinical Research (formerly Harvard Clinical Research Institute, for the PORTICO trial, funded by St. Jude Medical, now Abbott), Cleveland Clinic (including for the ExCEED trial, funded by Edwards), Contego Medical (Chair, PERFORMANCE 2), Duke Clinical Research Institute, Mayo Clinic, Mount Sinai School of Medicine (for the ENVISAGE trial, funded by Daiichi Sankyo), Novartis, Population Health Research Institute; Honoraria: American College of Cardiology (Senior Associate Editor, <i>Clinical Trials and News<\/i>, ACC.org; Chair, ACC Accreditation Oversight Committee), Baim Institute for Clinical Research (formerly Harvard Clinical Research Institute; RE-DUAL PCI clinical trial steering committee funded by Boehringer Ingelheim; AEGIS-II executive committee funded by CSL Behring), Belvoir Publications (Editor in Chief, <i>Harvard Heart Letter<\/i>), Canadian Medical and Surgical Knowledge Translation Research Group (clinical trial steering committees), Duke Clinical Research Institute (clinical trial steering committees, including for the PRONOUNCE trial, funded by Ferring Pharmaceuticals), HMP Global (Editor in Chief, <i>Journal of Invasive Cardiology<\/i>), <i>Journal of the American College of Cardiology<\/i> (Guest Editor; Associate Editor), K2P (Co-Chair, interdisciplinary curriculum), Level Ex, Medtelligence\/ReachMD (CME steering committees), MJH Life Sciences, Population Health Research Institute (for the COMPASS operations committee, publications committee, steering committee, and USA national co-leader, funded by Bayer), Slack Publications (Chief Medical Editor, <i>Cardiology Today\u2019s Intervention<\/i>), Society of Cardiovascular Patient Care (Secretary\/Treasurer), WebMD (CME steering committees); Other: <i>Clinical Cardiology<\/i> (Deputy Editor), NCDR-ACTION Registry Steering Committee (Chair), VA CART Research and Publications Committee (Chair); Research Funding: Abbott, Afimmune, Amarin, Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Cardax, CellProthera, Cereno Scientific, Chiesi, CSL Behring, Eisai, Ethicon, Ferring Pharmaceuticals, Forest Laboratories, Fractyl, Garmin, HLS Therapeutics, Idorsia, Ironwood, Ischemix, Janssen, Lexicon, Lilly, Medtronic, MyoKardia, NirvaMed, Novartis, Novo Nordisk, Owkin, Pfizer, PhaseBio, PLx Pharma, Regeneron, Roche, Sanofi, Synaptic, The Medicines Company, 89Bio; Royalties: Elsevier (Editor, <i>Cardiovascular Intervention: A Companion to Braunwald\u2019s Heart Disease<\/i>); Site Co-Investigator: Abbott, Biotronik, Boston Scientific, CSI, St.\u00a0Jude Medical (now Abbott), Philips, Svelte; Trustee: American College of Cardiology; Unfunded Research: FlowCo, Merck, Takeda. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}